To homepage
820К+ patients have got assistance since 2014
50 countries
1,500 clinics
6K+ reviews
3K+ qualified doctors

What's the Cost of Multiple sclerosis Diagnosis and Treatment in Republic of Korea?

Multiple sclerosis treatment cost in the Republic of Korea typically includes complex diagnostics of multiple sclerosis ranging from $1,700 to $3,200 and brain MRI with contrast which runs $700 to $1,200. Primary options like medication treatment for multiple sclerosis cost $14,500 to $34,500. Expenses depend on the therapeutic approach, disease stage, and clinic tier. Patients often save 30-50% compared to the US. Seoul and Cheonan are the primary medical hubs.

Typical Multiple Sclerosis Treatment Costs in Republic of Korea

  • Complex diagnostics of multiple sclerosis: $1,700 – $3,200
  • Brain MRI with contrast: $700 – $1,200
  • Visual Evoked Potentials (VEP-test): $200 – $300
  • Medication treatment for multiple sclerosis: $14,500 – $34,500
  • Multiple sclerosis rehabilitation: $15,200 – $28,000
  • Ocrevus (ocrelizumab): $18,200 – $23,400
  • Plasmapheresis: $4,200 – $7,500
  • Consultation with a neurologist: $28 – $100
  • Extended analysis of blood: $100 – $200
  • OCT (Optical coherence tomography): $100 – $200

Bookimed Expert Insight: For patients seeking advanced neurological care, JCI-accredited centers like Samsung Medical Center provide presidential-standard infrastructure. Those requiring specialized rehabilitation should consider Severance Hospital, which treats over 400,000 inpatients annually. Patients interested in experimental approaches can find unique arterial stem cell therapy at RE:YOUTH Clinic in Cheonan. Leading experts like Dr. Byung-hee Lee offer specialized interventional neurology protocols for complex cases.

Republic of KoreaTurkeyAustria
Plasmapheresisfrom $4,200from $1,200from $2,000
Ocrevus (ocrelizumab)from $18,200from $10,000from $35,000
Multiple sclerosis rehabilitationfrom $15,200from $3,000from $10,000
Medication treatment for multiple sclerosisfrom $14,500from $2,500from $2,000
Therapeutic Apheresis-from $1,350-
Data verified by Bookimed as of July 2026, based on patient requests and official quotes from 165 clinics worldwide. Median costs are based on real invoices (2025–2026) and updated monthly. Actual prices may vary.

Your Benefits and Guarantees with Bookimed

Transparent Prices & Flexible Installments

No hidden fees – just official clinic prices. Pay at the clinic for Multiple sclerosis treatment and use a flexible installment plan if needed.

Verified Clinics & Doctors Only

Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Multiple sclerosis treatment and have the necessary licenses to serve international patients worldwide.

Free 24/7 Assistance

Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Multiple sclerosis treatment journey.

Why we?

Your personal Bookimed medical coordinator

  • Supports you at every stage
  • Helps choose the right clinic and doctor
  • Ensures quick and convenient access to information

Best Multiple sclerosis Treatment Centers in Republic of Korea: 9 Verified Options and Prices

The Bookimed clinic ranking is based on data science algorithms, providing a trusted, transparent, and objective comparison. It takes into account patient demand, review scores (both positive and negative), the frequency of updates to treatment options and prices, response speed, and clinic certifications.
Samsung Medical Center
Seoul National University Bundang Hospital (SNUBH)

Get a Medical Assessment for Multiple sclerosis in Republic of Korea: Consult with Experienced Doctors Now

View all Doctors
verified

Kwang Ho Lee

Professor Kwang Ho Lee brings neurology expertise to Samsung Medical Center.

  • Professor of Neurology
  • Expert in neurodegenerative conditions
  • Practices at a leading medical institution
verified

Byung-hee Lee

42 years of experience

Dr. Lee is a founding member of the Korean Society of Interventional Neurology and the Korean Stroke Society, with extensive contributions to cerebrovascular research.

  • Regular member of the American Stroke Association and World Stroke Society
  • Presented 24 SCI theses and delivered 50 conference lectures
  • Specializes in interventional neurology with a focus on stroke and cerebrovascular conditions
verified

Kim Seung Min

Dr. Kim Seung Min is a neurologist at Severance Hospital.

  • Specializes in multiple sclerosis
verified

Kyoung Heo

The doctor is a leading neurologist in South Korea, specializing in epilepsy treatment. Currently, the doctor serves as the Head of the Neurology Department at Yonsei Severance Hospital.

The doctor graduated from Yonsei University College of Medicine and is an active member of several professional organizations, including The Korean Epilepsy Society, The Korean Neurological Association, and The Korea Medical Association.

Related Articles

Share this content

Video Stories from Bookimed Patients

Dayana
I combined my vacation in Antalya with a check-up.
Procedure: Female check-up
Igor
It was great! Transfers, accommodation, treatment—all included.
Procedure: Dental Implant
Marina
Bookimed did everything for me. I didn't have to worry about anything.
Procedure: Female check-up
Updated: 05/27/2022
Authored by
Anna Leonova
Anna Leonova
Head of Content Marketing Team
A certified medical writer with 10+ years of experience, developed Bookimed’s trusted content, backed by a Master’s in Philology and medical expert interviews worldwide.
Fahad Mawlood
Medical Editor & Data Scientist
General practitioner. Winner of 4 scientific awards. Served in Western Asia. Former Team Leader of a medical team supporting Arabic-speaking patients. Now responsible for data processing and medical content accuracy.
Fahad Mawlood Linkedin
This page may feature information relating to various medical conditions, treatments, and healthcare services available in different countries. Please be advised that the content is provided for informational purposes only and should not be construed as medical advice or guidance. Please consult with your doctor or a qualified medical professional before starting or changing medical treatment.

Expert Overview about Multiple sclerosis Treatment in Republic of Korea

These FAQs come from real patients seeking medical assistance through Bookimed. Answers are given by experienced medical coordinators and trusted clinic representatives.

What are the approved disease-modifying treatments (DMTs) available for multiple sclerosis in South Korea?

The South Korean Ministry of Food and Drug Safety (MFDS) has approved over 11 disease-modifying treatments (DMTs) for multiple sclerosis. These include high-efficacy infusions like Ocrevus (ocrelizumab) and Tysabri, alongside oral modulators such as Gilenya and Mayzent for managing relapses and progression.

  • Injectable therapies: Includes first-line options like Interferon beta-1a, Interferon beta-1b, and Glatiramer Acetate.
  • Oral medications: Features S1P modulators like Fingolimod, Dimethyl Fumarate, Teriflunomide, and Cladribine.
  • Infusion therapies: High-potency treatments include Ocrelizumab (Ocrevus), Natalizumab (Tysabri), Alemtuzumab (Lemtrada), and Mitoxantrone.
  • Emerging approaches: Specialized clinics like RE:YOUTH offer alternative cellular protocols including arterial stem cell therapy.

Bookimed Expert Insight: While several DMTs are approved, South Korea's therapeutic landscape heavily favors large multidisciplinary centers like Samsung Medical Center or Severance Hospital. These facilities handle millions of patients annually and provide the specialized MRI and VEP diagnostics required for DMT monitoring. Patients should note that newer infusions like Ocrevus are often reserved for cases where first-line interferons failed.

Patient Consensus: Patients note that securing insurance approval for newer oral or infusion DMTs can take 6–12 months. Many report starting with older injectable therapies while waiting for documentation to support a switch to high-efficacy medications.

May international patients enrol in autologous hematopoietic stem-cell transplantation (AHSCT) for MS in South Korea?

International patients can enroll in autologous hematopoietic stem-cell transplantation (AHSCT) for multiple sclerosis in South Korea, though access often depends on residency status or participation in clinical trials. Facilities like RE:YOUTH (YONSEI BH Arterial Stemcell Clinic) specialize in advanced regenerative protocols for global patients.

  • Regulatory access: New 2025 laws allow access to regenerative technologies for serious incurable conditions.
  • Leading institutions: JCI-accredited Severance Hospital and Samsung Medical Center provide advanced neurological care.
  • Specialized expertise: Dr. Byung-hee Lee offers innovative arterial delivery methods for stem cell therapies.
  • Accreditation standards: Top clinics hold KOIHA and ISO certifications, ensuring high-quality safety protocols.

Bookimed Expert Insight: While major centers like Asan Medical Center are highly ranked globally, international patients often find faster enrollment at specialized clinics like RE:YOUTH. These smaller, focused institutions specifically design their patient flow and medical coordination to accommodate foreigners without the local insurance requirements often seen at large state-level hospitals.

Patient Consensus: Patients note that navigating major hospital systems may require local residency proof. Many recommend contacting international departments directly to clarify if English-speaking support is available during the intensive chemotherapy phase.

How long after disease-modifying therapy must I stop before beginning AHSCT, and how is bridging therapy managed in Korea?

Standard washout periods for disease-modifying therapies (DMTs) before AHSCT in South Korea typically range from 6 weeks to 6 months. Durations depend on drug half-life and immune impact, with high-potency drugs like natalizumab often requiring 12 weeks to minimize infectious risks like progressive multifocal leukoencephalopathy.

  • Natalizumab washout: Patients generally wait 12 weeks to prevent rebound relapses or JC virus activation.
  • Ocrelizumab protocol: A 3-month pause is standard to manage B-cell depletion before intensive conditioning.
  • Bridging therapy: Korean specialists frequently use corticosteroids or cyclophosphamide to suppress inflammation during transitions.
  • Immediate initiation: Bridging often begins after leukapheresis to prevent disease activity before high-dose chemotherapy.

Bookimed Expert Insight: Patients seeking AHSCT in Seoul should prioritize JCI-accredited centers like Severance Hospital or Samsung Medical Center. These facilities handle massive patient volumes, with Samsung alone treating over 11,000 outpatients daily. This high-capacity environment allows neurologists like Dr. Kim Seung Min to implement sophisticated bridging protocols. Our data shows these leading centers often integrate advanced diagnostics, such as brain MRI with contrast and OCT, to monitor disease stability throughout the delicate washout phase.

Patient Consensus: Patients emphasize that washout schedules are highly personalized based on their specific medication history. They often note that starting the process early with a specialized neuro-transplant team helps manage the emotional stress of potential flares during the waiting period.

What length of stay and monitoring schedule are required for SphenoCath (sphenopalatine-ganglion) pulsed radiofrequency or Botulinum neurotoxin injections used for MS-related trigeminal neuralgia in Seoul clinics?

Seoul clinics perform SphenoCath pulsed radiofrequency and Botox injections for MS-related trigeminal neuralgia as outpatient procedures. Patients typically experience a same-day discharge following a 10 to 30 minute procedure. Clinical monitoring ranges from 15 minutes to 4 hours depending on the specific technique and patient mobility.

  • Procedure duration: Most injections take 10 to 20 minutes in a clinical setting.
  • Observation period: Immediate monitoring lasts 10 to 30 minutes to check for adverse reactions.
  • Botox follow-up: Evaluation occurs at 2 to 4 weeks to assess the peak effect.
  • Radiofrequency schedule: Initial follow-up at 1 week with tracking at 1, 3, and 6 months.

Bookimed Expert Insight: While these are outpatient procedures, the sheer scale of Seoul's top facilities like Samsung Medical Center or SNUH means high patient volumes. Samsung alone treats over 2,000,000 patients annually. This high repetition contributes to specialized neurologists like Dr. Kwang Ho Lee maintaining refined injection protocols for complex MS cases.

Patient Consensus: Patients note it is important to arrange transportation because driving is not allowed after the procedure. Some emphasize the need for a 1 to 4 hour observation window if they have mobility issues.

Do Korean hospitals provide full English interpreters and telemedicine follow-up after my treatment course?

Major South Korean tertiary hospitals provide professional English interpretation through dedicated International Healthcare Centers and increasingly offer telemedicine follow-up. Institutions like Severance Hospital and Samsung Medical Center employ bilingual coordinators to manage consultations, while remote monitoring via digital platforms facilitates post-treatment care for international patients.

  • Service availability: Specialized international clinics provide bilingual doctors and coordinators at top-tier facilities.
  • Interpretation support: Free scheduled services are common during initial consultations and major medical procedures.
  • Telemedicine access: Asan Medical Center offers remote consultations specifically to coordinate with home-country physicians.
  • Digital tools: Many facilities use mobile applications like KakaoTalk for real-time post-treatment recovery assistance.

Bookimed Expert Insight: While hospitals like Samsung Medical Center serve over 2,000,000 patients annually, high volume means English support is often strictly limited to clinical hours. Patients should confirm if their `international patient` status includes 24/7 digital access, as some portals require pre-enrollment to bypass domestic-only restrictions.

Patient Consensus: Patients note that while interpreters are excellent during surgeries, daily ward communication often requires translation apps. Many suggest testing hospital-specific telemed portals before discharge to ensure technical compatibility for remote follow-ups.

Where are the main medical hubs offering dedicated MS units and English-speaking staff?

Major medical hubs for multiple sclerosis in South Korea are concentrated in Seoul within the Big 5 hospital network. These JCI-accredited and KOIHA-certified centers, including Samsung Medical Center and Severance Hospital, provide dedicated neurology departments with English-speaking staff and advanced diagnostic infrastructure.

  • Diagnostic precision: Facilities utilize brain MRI with contrast and Optical Coherence Tomography (OCT).
  • Expert staff: Specialists like Dr. Kim Seung Min at Severance Hospital lead neurology care.
  • Institutional status: Samsung Medical Center serves as a high-volume hub with 1,400+ doctors.
  • International coordination: Asan Medical Center features a dedicated department for global patient services.

Bookimed Expert Insight: Data shows a clear distinction between multidisciplinary giants and niche clinics in Korea. While Seoul’s Big 5 hospitals like SNUH and Asan serve thousands of daily outpatients with standard disease-modifying therapies, RE:YOUTH in Cheonan offers a highly specialized arterial stem cell approach. Patients seeking cutting-edge alternatives often choose these smaller, tech-focused clinics that bypass traditional systemic delivery for direct organ targeting.

Patient Consensus: Patients note that sticking to Seoul’s top tier hospitals ensures the best English support through international clinics. While doctors often speak fluent English, having a translator app as a backup is recommended for interactions with general nursing staff.

What is the quality of care for multiple sclerosis treatment in the Republic of Korea compared to Australia?

South Korea offers high-quality multiple sclerosis care featuring specialised diagnostics and disease-modifying therapies. Treatment centres in Seoul provide JCI-accredited facilities and digital medical records. This compares well with Australia's specialist neurologists. However, Korea offers additional options like arterial stem cell therapy at specialised clinics.

  • Leading centres: Severance Hospital and Samsung Medical Center hold Newsweek rankings and KOIHA accreditation.
  • Specialised diagnostics: Clinics use optical coherence tomography and high-resolution brain MRI with contrast imaging.
  • Therapy options: Doctors provide disease-modifying therapies including Ocrevus and arterial stem cell infusions.
  • Expert specialists: Board-certified neurologists like Dr Kim Seung Min focus on neurodegenerative disorder trials.

Bookimed Expert Insight: South Korea's leadership in digital health helps international patients. Facilities like Seoul National University Bundang Hospital use the BESTcare digital system to reduce medical errors. This integration simplifies sharing MRI scans and treatment reports with Australian GPs for follow-up care.

Patient Consensus: Patients note that quality depends on finding an experienced neurologist and securing detailed English treatment summaries. Success in Korea often involves choosing clinics that provide MRI results and clear medication handovers for local Australian doctors.

What multiple sclerosis treatments are clinically available in the Republic of Korea?

South Korean clinics provide over 11 disease-modifying therapies (DMTs) approved by the Ministry of Food and Drug Safety. Specialists at JCI-accredited hubs like Severance Hospital offer high-efficacy infusions including Ocrevus and Tysabri. Neurological diagnostics integrate MRI and Visual Evoked Potentials (VEP) to monitor disease progression.

  • Infusion therapies: Clinics administer Ocrevus, Tysabri, and Lemtrada for relapsing MS forms.
  • Oral medications: Specialists prescribe S1P modulators like Gilenya and Mayzent for daily management.
  • Specialised procedures: Plasmapheresis is available to treat severe relapses by filtering the blood.
  • Specialised diagnostics: Centres use Optical Coherence Tomography (OCT) to detect early optic nerve damage.

Bookimed Expert Insight: South Korea specialises in high-volume neurological care. Severance Hospital alone manages 4,000,000 patients annually. This scale allows doctors like Dr Kim Seung Min to participate in global clinical trials. Patients benefit from doctors who see many complex neurodegenerative cases.

Is stem cell therapy or HSCT an option for multiple sclerosis treatment in the Republic of Korea?

Autologous Haematopoietic Stem Cell Transplant (AHSCT) is a specialised option for aggressive multiple sclerosis in South Korea. Major JCI-accredited hospitals in Seoul provide this immune-rebooting procedure. The process involves harvesting stem cells and intensive chemotherapy. This happens under strict Ministry of Food and Drug Safety regulations.

  • Hospital centres: Samsung Medical Center and Severance Hospital carry Newsweek World Best Hospital rankings.
  • Clinical expertise: Prof. Dr Kwang Ho Lee at Samsung specialises in neurodegenerative stem cell applications.
  • Accreditation standards: Facilities like Gangnam Severance Hospital maintain JCI accreditation for international safety protocols.
  • Specialised clinics: RE:YOUTH offers arterial stem cell therapy specifically for chronic and rare diseases.

Bookimed Expert Insight: South Korea is known for major hospitals, but clinics like RE:YOUTH limit intake. They see only 2 patients daily. This focus allows for intensive monitoring that high-volume hospitals may not provide. Samsung Medical Center handles over 2,000,000 cases annually. This offers massive clinical depth for complex immunological reboots.

Patient Consensus: Patients say it is essential to distinguish between stem cell injections and full HSCT. Many suggest confirming that neurology and haematology teams work together in Seoul.

How are acute multiple sclerosis relapses managed in the Republic of Korea?

South Korean hospitals manage acute multiple sclerosis relapses using high-dose intravenous steroids and plasmapheresis within JCI-accredited facilities. Specialists typically prescribe 1,000 mg of methylprednisolone daily for 3–5 days to reduce inflammation. Clinics in Seoul also provide specialised neuro-rehabilitation to restore function after neurological deficits.

  • First-line treatment: High-dose intravenous methylprednisolone pulse therapy addresses acute inflammation quickly.
  • Secondary options: Plasmapheresis (plasma exchange) is used for severe relapses unresponsive to steroids.
  • Specialised centres: Seoul National University Hospital serves over 10,000 daily patients with digitalised care.
  • Clinical diagnostics: Clinics use contrast-enhanced MRI and Optical Coherence Tomography (OCT) for assessments.

Bookimed Expert Insight: Samsung Medical Center and Severance Hospital consistently rank in Newsweek's World’s Best Hospitals. These centres serve 2,000,000 to 4,000,000 patients annually. This massive case volume means neurologists like Dr Kwang Ho Lee manage complex relapses daily. For Australians, this level of clinical experience exceeds what is typical in smaller domestic units.

Patient Consensus: Patients find that reaching a major tertiary hospital quickly is vital for urgent steroid treatment. They suggest bringing a symptom timeline and previous MRI scans to speed up the assessment in Korea.

What is the diagnostic process for international patients seeking multiple sclerosis assessment in the Republic of Korea?

International patients undergoing multiple sclerosis assessment in South Korea follow a structured neurology-led pathway. This typically includes a physical exam, brain MRI with contrast, and specialised testing like lumbar puncture. Diagnostics occur at JCI-accredited Seoul hospitals, often concluding within 1 to 3 weeks.

  • Neurological evaluation: Specialists like Dr Kim Seung Min assess nerve function and history.
  • Specialised imaging: Brain and spinal MRI with contrast identifies active demyelinating plaques.
  • Electrophysiological tests: Visual Evoked Potentials (VEP) measure the speed of signals through nerves.
  • Laboratory analysis: Lumbar puncture and blood tests rule out other similar neurological conditions.

Bookimed Expert Insight: South Korea's digitised healthcare system provides a distinct advantage for international patients. Clinics like Seoul National University Hospital have been fully digital since 2004. This allows for seamless transfers of high-resolution imaging and reports. Local specialists can review digital history quickly. This often reduces the number of days needed for the initial assessment phase.

Patient Consensus: Patients note the process requires several steps rather than one visit. Bringing prior MRI scans and a clear symptom timeline helps avoid repeating basic tests in Seoul or Incheon.

Do specialists in the Republic of Korea offer holistic support alongside multiple sclerosis treatment?

South Korean specialists provide holistic support by integrating neurology with rehabilitation and multidisciplinary care. Major JCI-accredited hubs like Severance Hospital and Asan Medical Center employ neurology teams. These teams coordinate with rehabilitation specialists to manage symptoms and improve daily quality of life.

  • Multidisciplinary care: Severance Hospital provides specialised rehabilitation centres alongside neurology to manage disease progression.
  • Clinical diagnostics: Clinics use optical coherence tomography and urodynamics to assess holistic physiological impact.
  • Expert coordination: Specialists like Dr. Kim Seung Min involve clinical trials for comprehensive patient care.
  • Specialised therapy: Centres involve recreation therapists to help patients maintain social and physical engagement.

Bookimed Expert Insight: While South Korean centres are known for digital efficiency, large university hospitals offer comprehensive support. For example, Severance Hospital serves 4,000,000 patients annually. These institutions house neurology, rehabilitation, and ophthalmology under one roof. This allows medical records to be shared instantly between departments for a unified treatment plan.

Patient Consensus: Patients find Korean medical care exceptionally precise. However, they often need to ask specialists for specific referrals to physiotherapy or nutrition. Many recommend confirming upfront if the neurologist manages the full care team in South Korea.

Get a free consultation

Select the best way to contact you